Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | DPP4 | P27487 | 3/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 4/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8167988 | 0.84 | DPP4 (0.45) | DPP4DPP8DPP9ELANE | |
| SCHEMBL3778456 | 0.83 | DPP4 (0.49) | DPP4DPP8DPP9ELANEKDM4E | |
| SCHEMBL2756268 | 0.81 | CYP3A4 (0.49) | DPP4DPP8DPP9ELANE | |
| SCHEMBL3268700 | 0.81 | CYP3A4 (0.49) | DPP4DPP8DPP9ELANE | |
| SCHEMBL8161391 | 0.79 | ELANE (0.43) | DPP4DPP8DPP9ELANE | |
| SCHEMBL8161377 | 0.78 | DPP4 (0.45) | DPP4DPP8DPP9ELANE | |
| SCHEMBL8143604 | 0.77 | CMA1 (0.53) | ELANE | |
| SCHEMBL8161374 | 0.77 | CMA1 (0.53) | ELANE | |
| SCHEMBL10875429 | 0.74 | TRHR (0.49) | ELANE | |
| SCHEMBL30798320 | 0.74 | EPHA2 (0.43) | DPP4DPP8DPP9ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008095058-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO. LTD. (TW) | 2008-08-07 | — | — | WO | disclosed |